Search filters

List of works by Ming-Lung Yu

A Functional Polymorphism at the FGF10 Gene Is Associated With Extreme Myopia

scientific article published on May 7, 2013

Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience

scientific article published on 24 May 2018

Association Between Screen-detected Gallstone Disease and Cancer in a Cohort Study

scientific article published on 05 October 2017

Association between gallbladder stones and chronic hepatitis C: Ultrasonographic survey in a hepatitis C and B hyperendemic township in Taiwan

scientific article published on February 20, 2013

Association between urinary thiodiglycolic acid level and hepatic function or fibrosis index in school-aged children living near a petrochemical complex

scientific article published on 06 October 2018

Association between virological response and decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in HCV genotype 1: another story

scientific article published on May 1, 2011

Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication

scientific article published on 10 July 2018

Chronic hepatitis C infection in the elderly

scientific article published on November 25, 2011

Chronic hepatitis C infection is associated with insulin resistance and lipid profiles

scientific article published on May 1, 2015

Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients.

scientific article

Clinical significance of TT virus (TTV) infection in chronic hepatitis C patients with high dose interferon-alpha therapy in Taiwan: re-evaluated by using new set of TTV primers

scientific article published on October 1, 2003

Clinical utility of host genetic IL‐28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin

scientific article published on September 1, 2013

Coexistence of focal nodular hyperplasia and pseudotumor caused by focal spared lesion in the liver of a young man

scientific article published on 01 November 2003

Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan

scientific article published on 25 October 2018

Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic hepatitis B and chronic hepatitis C in Taiwan

scientific article published on August 9, 2010

Comparison of the Abbott RealTime HBV assay with the Roche Cobas AmpliPrep/Cobas TaqMan HBV assay for HBV DNA detection and quantification.

scientific article published on 13 April 2014

Cure with Interferon Free DAA is Associated with Increased Survival in Patients with HCV related HCC from both East and West

scientific article published on 14 October 2019

Daclatasvir/Asunaprevir/Beclabuvir (DCV-TRIO), All-Oral, Fixed-Dose Combination for Patients With Chronic HCV Genotype 1.

scientific article

Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions

scientific article published on 05 December 2018

Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy

scientific article published on 06 October 2020

Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C)

scientific article published on 10 December 2020

Evolution of interferon-based therapy for chronic hepatitis C.

scientific article

Exosome-derived differentiation antagonizing non-protein coding RNA with risk of HCV-related hepatocellular carcinoma recurrence

scientific article published on 21 December 2020

GB virus C/hepatitis G virus infection in chronic hepatitis C patients with and without interferon-α therapy

scientific article published on December 1, 2001

Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis

scientific article published on December 6, 2012

Heparin at physiological concentration can enhance PEG-free in vitro infection with human hepatitis B virus

scientific article published on 31 October 2017

Hepatitis B virus dual infection disrupts platelet count recovery in chronic hepatitis C patients with curative antiviral therapy.

scientific article published on 11 October 2017

Hepatitis C treatment from "response-guided" to "resource-guided" therapy in the transition era from interferon-containing to interferon-free regimens

scientific article published on 26 January 2017

Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals

scientific article published on 19 June 2019

Host factors determining the efficacy of hepatitis C treatment.

scientific article published on 27 October 2012

Host interleukin-28B genetic variants versus viral kinetics in determining responses to standard-of-care for Asians with hepatitis C genotype 1

scientific article published on December 13, 2011

Improvement of Nonalcoholic Fatty Liver Disease After Bariatric Surgery in Morbidly Obese Chinese Patients

scientific article published on July 1, 2012

Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agents

scientific article published on 10 September 2019

Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin

scientific article published on May 19, 2011

Less liver fibrosis marker increment in overweight chronic hepatitis B patients observed by age-adjusted Fibrosis-4 Index

scientific article published on 01 December 2020

Letter to the Editors: Regional Epidemics of Nonalcoholic Fatty Liver Disease: Timing of Westernization and Ethnicity Matter

scientific article published on 22 January 2020

Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resection

scientific article published in Scientific Reports

Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection

scientific article published on 08 February 2019

Multi-center evaluation of the Abbott RealTime HCV Assay for monitoring patients undergoing antiviral therapy for chronic hepatitis C

scientific article published on July 30, 2011

Outcome of patients suffering from a spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure and treated with antivirals

scholarly article by Chia-Yen Dai et al published 27 June 2011 in Hepatology

Path from the discovery to the elimination of hepatitis C virus: Honoring the winners of the Nobel Prize in Physiology or Medicine 2020

scientific article published on 18 December 2020

Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection

scientific article published on January 1, 2010

Pegylated interferon and ribavirin: a therapeutic option in patients who fail to respond to telaprevir-based triple therapy?

scientific article published on August 14, 2013

Prevalence and manifestations of hepatitis C seropositivity in children in an endemic area

scientific article published on February 1, 1998

Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype

scientific article published on April 1, 2013

Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals.

scientific article published on 23 February 2017

Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study

scientific article published on 15 November 2018

Reply to "Rescue for interferon failures in HCV genotype 1/HBV dually infection"

scientific article published on 03 July 2018

Reply to "cost effectiveness of hepatitis C treatments: Need for a comprehensive evaluation".

scientific article published on 13 July 2017

Resistance-Associated Substitutions in Short Duration of Interferon-Free Direct-Acting Antivirals for Hepatitis C.

scientific article

Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevir

scientific article published on 15 August 2019

Serial serologic changes of hepatitis D virus in chronic hepatitis B patients receiving nucleos(t)ides analogues therapy

scientific article published on 04 April 2020

Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients

scientific article published on August 4, 2010

Severe acute exacerbation of HCV infection in cancer patients who undergo chemotherapy: some issues

scientific article published on 05 July 2020

Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH)

scientific article published on 31 August 2020

Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up

scientific article published on April 26, 2013

Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis

scientific article published on 25 March 2020

The 8-oxoguanine glycosylase I (hOGG1) Ser326Cys variant affects the susceptibility to multi-vessel disease in Taiwan coronary artery disease patients

scientific article published on July 27, 2010

The Paradoxical Effects of Different Hepatitis C Viral Loads on Host DNA Damage and Repair Abilities

scientific article

The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies – A multicenter prospective trial

scientific article published on September 7, 2010

The importance of the definition of early virological response for predicting treatment efficacy for chronic hepatitis C

scientific article published on April 1, 2011

The outcomes of glucose abnormalities in pre‐diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy

scientific article published on February 22, 2012

The response of hepatitis C virus and TT virus to high dose and long duration interferon-alpha therapy in naı̈ve chronic hepatitis C patients

scientific article published on January 1, 2002

Thyroid autoantibodies and dysfunction do not impact the treatment efficacy of peginterferon and ribavirin combination therapy in chronic hepatitis C

scientific article published on August 18, 2011

Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antivirals

scientific article published in Scientific Reports

Treatment of chronic hepatitis C in Asia: when East meets West.

scientific article

Viral Interference Between Dengue Virus and Hepatitis C Virus Infections

scientific article published on 03 July 2020

Virological Predictors of Response to Retreatment in Hepatitis C Genotype 2 Infected Patients

scientific article published on March 19, 2013

Waist circumference, body mass index, serum uric acid, blood sugar, and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese population

scientific article published on July 7, 2012